Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Inhibition of Fatty Acid Binding Protein 4 in Obese Male Mice Adversely Affects Reproductive Parameters

Authors
Tevfik Balci 1
Rahim Kocabas 2
Gokhan Cuce 3
Mehmet Akoz 4
1 Osmaniye Provincial Health Directorate, Public Health Laboratories, Osmaniye, Turkey
2 Department of KONUDAM Experimental Medicine Application and Research, Necmettin Erbakan University, Meram, Konya, Turkey
3 Department of Histology and Embryology, Faculty of Meram Medicine, Necmettin Erbakan University, Konya, Turkey
4 Department of Biochemistry, Faculty of Meram Medicine, Necmettin Erbakan University, Konya, Turkey
10.18502/jri.v22i1.4991
Abstract
Background: As obesity is increasing worldwide, obese people use various methods to get rid of excess weight. BMS309403 (A drug) is a specific inhibitor of fatty acid binding protein 4. In this study, the effects of the BMS309403 on serum biochemical markers, testis tissue spermatogenesis and apoptotic markers were investigated in male mice. Methods: Balb/c mice (total=56, each group n=14) were divided into control, obese control, obese solvent and obese drug groups. The obese control, obese solvent and obese drug groups were fed on the high sucrose diet to lead to obesity. After the development of obesity, BMS309403 was orally administered to the obese drug group for six weeks. It was performed in testicular tissues (Johnson Score and apoptosis markers) and biochemical tests (total testosterone, sex hormone binding globulin, inhibin-B tests and free androgen index) were used to evaluate reproductive parameters. The p<0.05 was considered to indicate a statistical significance. Results: Serum fatty acid binding protein 4 levels were higher in obese control group and obese solvent group, compared to control (p<0.05) and obese drug groups (p<0.001). Serum total testosterone, free androgen index, inhibin-B, sex hormone binding globulin levels, testicular tissue B-cell lymphoma-2 expression level and Johnson Score parameters were lower in all obese groups compared with the control group. Inhibin-B levels and Johnson Score results were lower in obese drug group compared to other two obese groups (p<0.05). Conclusion: Contrary to expectations, the use of BMS309403 negatively affected male reproductive parameters. Negative changes in reproductive parameters may be a result of the increased lee index of obesity.
Keywords
BMS309403
Experimental obesity
Fatty acid binding protein
Male fertility impairment
Mice
Side
effect
  1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study. Lancet. 2014;384(9945):766-81.
  2. Palmer NO, Bakos HW, Fullston T, Lane M. Impact of obesity on male fertility, sperm function and molecular composition. Spermatogenesis. 2012;2(4):253-63.
  3. Youngson NA, Whitelaw E. The effects of acquired paternal obesity on the next generation. Asian J Androl. 2011;13(2):195-6.
  4. Kralisch S, Fasshauer M. Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia. 2013;56(1):10-21.
  5. Okada T, Hiromura M, Otsuka M, Enomoto S, Miyachi H. Synthesis of BMS-309403-related compounds, including [14C]BMS-309403, a radioligand for adipocyte fatty acid binding protein. Chem Pharm Bull (Tokyo). 2012;60(1):164-8.
  6. Furuhashi M, Tuncman G, Görgün CZ, Makowski L, Atsumi G, Vaillancourt E, et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature. 2007;447(7147):959-65.
  7. Suhre K, Römisch-Margl W, De Angelis MH, Adamski J, Luippold G, Augustin R. Identification of a potential biomarker for FABP4 inhibition: The power of lipidomics in preclinical drug testing. J Biomol Screen. 2011;16(5):467-75.
  8. Plocher TA, Powley TL. Maintenance of obesity following hypophysectomy in the obese hyperglycemic mouse (ob/ob). Yale J Biol Med. 1997;50(3):291-300.
  9. Hilwani IN, Nasibah R, Nurdiana S, Norashirene MJ. Gonadotoxic and cytotoxic effect of induced obesity via monosodium glutamate on mus musculus testis cytoarchitecture and sperm parameter. Int J Agric Biosyst Eng. 2014;8(9):1000-3.
  10. Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, Kang MJ, et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011;73:479-501.
  11. Novelli EL, Diniz YS, Galhardi CM, Ebaid GM, Rodrigues HG, Mani F, et al. Anthropometrical parameters and markers of obesity in rats. Lab Anim. 2007;41(1):111-9.
  12. Ritze Y, Bárdos G, D'Haese JG, Ernst B, Thurnheer M, Schultes B, et al. Effect of high sugar intake on glucose transporter and weight regulating hormones in mice and humans. PLoS One. 2014;9(7):e101702.
  13. Al Kindi MK, Al Essry FS, Al Essry FS, Mula-Abed WA. Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism. Oman Med J. 2012;27(6):471-4.
  14. Cai WJ, Huang JH, Zhang SQ, Wu B, Kapahi P, Zhang XM, et al. Icariin and its derivative icariside II extend healthspan via insulin/IGF-1 pathway in C. elegans. PLoS One. 2011;6(12):e28835.
  15. Yang R, Castriota G, Chen Y, Cleary MA, Ellsworth K, Shin MK, et al. RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice. Int J Obes (Lond). 2011;35(2):217-25.
  16. Hotamisligil GS, Bernlohr DA. Metabolic functions of FABPs - mechanisms and therapeutic implications. Nat Rev Endocrinol. 2015;11(10):592-605.
  17. Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity: Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor γ and IκB kinase activities. J Biol Chem. 2005;280(13):12888-95.
  18. Bourlier V, Bouloumie A. Role of macrophage tissue infiltration in obesity and insulin resistance. Diabetes Metab. 2009;35(4):251-60.
  19. Baar RA, Dingfelder CS, Smith LA, Bernlohr DA, Wu C, Lange AJ, et al. Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice. Am J Physiol Endocrinol Metab. 2005;288(1): E187-93.
  20. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology. 2000;141(9):3388-96.
  21. Kasturi SS, Tannir J, Brannigan RE. The metabolic syndrome and male infertility. J Androl. 2009;29(3):251-9.
  22. Pinilla L, Seoane LM, Gonzalez L, Carro E, Aguilar E, Casanueva FF, et al. Regulation of serum leptin levels by gonadal function in rats. Eur J Endocrinol. 1999;140(5):468-73.
  23. Wang C, McDonald V, Leung A, Superlano L, Berman N, Hull L, et al. Effect of increased scrotal temperature on sperm production in normal men. Fertil Steril. 1997;68(2):334-9.
  24. Chambers TJ, Richard RA. The impact of obesity on male fertility. Hormones (Athens). 2015;14(4): 563-8.
Journal of Reproduction & Infertility
Volume 22, Issue 1
Winter 2021
Pages 16-22